JPRN-UMIN000003295
Recruiting
Phase 1
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia. - Phase I study for the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia
Tokyo Women's Medical University of Medicine, Department of Surgery I0 sites30 target enrollmentMarch 6, 2010
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothorax
- Sponsor
- Tokyo Women's Medical University of Medicine, Department of Surgery I
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Having the history of allergic reaction against ulinastatin. 2\.Asbestosis. 3\.Chronic hypersensitivity pneumonitis. 4\.Sarcoidosis. 5\.Pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
Investigating targEting LysyL oxIdase tO ameliorate scarring in burn Traumaburn injurySkin - Other skin conditionsInjuries and Accidents - BurnsACTRN12623001071617university of western australia60
Active, not recruiting
Not Applicable
A study to find out whether treating patients who have liver metastases from eye melanoma with radiofrequency ablation combined with ipilimumab, will kill the tumor without them having too many adverse events.EUCTR2011-004200-38-NLKI-AV
Completed
Not Applicable
Safety and Efficacy of the Adapt Pericardial Patch in the repair of defects associated with congenital heart disease in participants aged between 1 and 12 years of ageCongenital Heart Disease including ventricular septal defect repair, atrial ventricular septal defect, atrio ventricular septal defects as determined by clinical assessment including MRI and echo cardiographyCardiovascular - Other cardiovascular diseasesACTRN12613000308796A/Professor Christian Brizard40
Not yet recruiting
Not Applicable
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
Terminated
Not Applicable
A phase I study to determine the efficacy and safety of CKD-516 tablet combined with durvalumab(MEDI4736) in patient refractory solid tumorsKCT0005756Asan Medical Center42